Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6088 (MIR6088) is a short non-coding RNA molecule belonging to the microRNA (miRNA) family, which regulates gene expression post-transcriptionally in human cells[1]. Like other miRNAs, it is produced from larger transcripts processed by Drosha and Dicer enzymes to yield a mature miRNA that becomes part of the RISC machinery, guiding sequence-specific repression of target mRNAs[1][5]. MIR6088 has been noted as one component of a multi-miRNA biomarker panel for sarcoma diagnosis, but there is little to no independent literature on its specific biological roles, disease relevance, or utility as a therapeutic target[2]. There is no current evidence that MIR6088 has well-characterized, direct disease associations or pharmacologic targeting, and no information suggesting it is a standalone therapeutic target.
Binds target mRNAs as part of RNA-induced silencing complex (RISC), leading to translational inhibition or mRNA degradation[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6088 (MIR6088).